Cargando…

Receptor Activator of Nuclear Factor Kappa B (RANK) and Clinicopathological Variables in Endometrial Cancer: A Study at Protein and Gene Level

The system integrated by the receptor activator of nuclear factor kappa B (RANK) and its ligand, RANKL, modulates the role of hormones in the genesis and progression of breast tumors. We investigated whether the expression of RANK was related with clinicopathological features of primary endometrial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gómez, Raúl, Castro, Ana, Martínez, Jessica, Rodríguez-García, Víctor, Burgués, Octavio, Tarín, Juan J., Cano, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073139/ https://www.ncbi.nlm.nih.gov/pubmed/29932437 http://dx.doi.org/10.3390/ijms19071848

Ejemplares similares

Histological Grade and Tumor Stage Are Correlated with Expression of Receptor Activator of Nuclear Factor Kappa b (Rank) in Epithelial Ovarian Cancers
por: Gomez, Raul, et al.
Publicado: (2022)

Evaluation of the Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) Expression in Osteosarcoma and Its Association with the Clinicopathological Data
por: Chua, Hui Heng, et al.
Publicado: (2021)

Association of a single nucleotide polymorphism of RANK gene with blood pressure in Spanish women
por: Pertusa, Clara, et al.
Publicado: (2020)

Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
por: Pacifico, Lucia, et al.
Publicado: (2018)

Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand/receptor activator of nuclear factor kappa-B signaling
por: Zhang, Luodan, et al.
Publicado: (2022)

Clinicopathological roles of adiponectin and leptin receptors in endometrial carcinoma
por: YABUSHITA, HIROMITSU, et al.
Publicado: (2014)

Asymptotic variability of (multilevel) multirater kappa coefficients
por: Vanbelle, Sophie
Publicado: (2018)

Clinicopathologic Features of Membranous-Like Glomerulopathy With Masked IgG Kappa Deposits
por: Larsen, C.P., et al.
Publicado: (2016)

Nuclear factor kappaB (NF-kappaB) pathway as a therapeutic target in rheumatoid arthritis.
por: Jue, D. M., et al.
Publicado: (1999)

Role of nuclear factor-kappa B in feline injection site sarcoma
por: Hsueh, Cheng-Shun, et al.
Publicado: (2019)

Expression of Nuclear Factor Kappa B and Survivin in Psoriasis
por: Gunduz, Kamer, et al.
Publicado: (2012)

The dichotomy of inhibiting nuclear factor kappa-B in pneumonia
por: Abraham, Edward
Publicado: (2013)

Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
por: Miraghazadeh, Bahar, et al.
Publicado: (2018)

Neuroinflammation in schizophrenia: the role of nuclear factor kappa B
por: Murphy, Caitlin E., et al.
Publicado: (2021)

Nuclear Factor-Kappa B Regulation of Osteoclastogenesis and Osteoblastogenesis
por: Boyce, Brendan F., et al.
Publicado: (2023)

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
por: León‐Castillo, Alicia, et al.
Publicado: (2020)

Osteonecrosis of the jaw induced by receptor activator of nuclear factor-kappa B ligand (Denosumab) - Review
por: de Oliveira, Camila-Carvalho, et al.
Publicado: (2016)

Clinicopathological Prognostic Parameters of Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
por: Vachliotis, Ilias D., et al.
Publicado: (2023)

Androgen receptor expression in endometrial carcinoma and its correlation with clinicopathologic features
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Empirical evaluation of SUCRA-based treatment ranks in network meta-analysis: quantifying robustness using Cohen’s kappa
por: Daly, Caitlin H, et al.
Publicado: (2019)

Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
por: Godwin, P., et al.
Publicado: (2013)

Glucocorticoid receptor and nuclear factor kappa-b affect three-dimensional chromatin organization
por: Kuznetsova, Tatyana, et al.
Publicado: (2015)

Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer
por: Banno, Kouji, et al.
Publicado: (2013)

Clinicopathologic features of endometrial cancer with mismatch repair deficiency
por: Gordhandas, Sushmita, et al.
Publicado: (2020)

SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship
por: Zhu, Qing, et al.
Publicado: (2022)

A Reassessment of the Therapeutic Potential of a Dopamine Receptor 2 Agonist (D2-AG) in Endometriosis by Comparison against a Standardized Antiangiogenic Treatment
por: Tejada, Miguel Á., et al.
Publicado: (2021)

Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study
por: Lessard, L, et al.
Publicado: (2005)

Role of RANK and Akt1 activation in human osteosarcoma progression: A clinicopathological study
por: Zhu, Jianxi, et al.
Publicado: (2017)

Inhibitors of nuclear factor kappa B cause apoptosis in cultured macrophages
por: Mannick, E. E., et al.
Publicado: (1997)

A Study of Nuclear Transcription Factor-Kappa B in Childhood Autism
por: Naik, Usha S., et al.
Publicado: (2011)

Activation of Nuclear Factor-kappa B signalling promotes cellular senescence
por: Rovillain, Emilie, et al.
Publicado: (2011)

Role of nuclear factor kappa B in central nervous system regeneration
por: Engelmann, Christian, et al.
Publicado: (2014)

Development of DNA Pair Biosensor for Quantization of Nuclear Factor Kappa B
por: Wang, Zhaohui, et al.
Publicado: (2018)

Receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in gingival crevicular fluid
por: Sarlati, Fatemeh, et al.
Publicado: (2012)

Kappa /
por: Akutagawa, Ryūnosuke, 1892-1927
Publicado: (1985)

The Clinicopathological Significance and Prognostic Value of Androgen Receptor in Endometrial Carcinoma: A Meta-Analysis
por: Wu, Xirong, et al.
Publicado: (2022)

Expression of CD47 in Endometrial Cancer and Its Clinicopathological Significance
por: Yang, Mei, et al.
Publicado: (2022)

Retracted: SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Clinicopathological and molecular pathological characteristics in tamoxifen‑related endometrial cancer
por: Saeki, Harumi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1urrjt1nk625ma3a2rjsq2299f